NCT06650293

Effect of Vitamin D Supplementation as Adjuvant Therapy in Neonatal Jaundice in Combination With Phototherapy

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Muhammad Aamir Latif · Academic / Other
• Sex: All
• Age: 3 Days – 28 Days
• Healthy volunteers: Not accepted

Summary

Neonatal jaundice frequently occur during initial week of life. Neonatal jaundice is one of the leading causes of hospital admission and readmission. Some studies have suggested that the healthy newborns with hyperbilirubinemia outside the physiological range have notably reduced serum vitamin D levels. This deficiency is inversely associated with neonatal hyperbilirubinemia, suggesting that low vitamin D levels could be a potential risk factor for jaundice among neonates.

Conditions

• Neonatal Jaundice

Interventions

Type	Name	Description
DRUG	Vitamin D	Vitamin D supplementation as vitamin D, 2 drops i.e., 800 IU daily for 5 days.

Timeline

• Start date: 2022-05-10
• Primary completion: 2022-11-09
• Completion: 2022-11-10
• First posted: 2024-10-21
• Last updated: 2024-10-21

Locations

1 site across 1 country: Pakistan